Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
BMED
55
HOLDINGS
38%
ALSO IN HRTS
HRTS
42
HOLDINGS
40%
ALSO IN BMED
SECTOR DRIFT (BMED minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 4.1% | 4.3% | 4.1% |
|
JOHNSON & JOHNSON | 7.9% | 3.6% | 3.6% |
|
GILEAD SCIENCES INC | 5.5% | 3.4% | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 2.9% | 2.9% | 2.9% |
|
DANAHER CORP | 2.5% | 2.7% | 2.5% |
BMED Overweight Relative to HRTS
|
JOHNSON & JOHNSON | 4.3% |
|
BIOGEN IDEC INC | 3.6% |
 |
WUXI BIOLOGICS (CAYMAN) INC. | 3.2% |
|
WATERS CORP | 3.2% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.1% |
|
EDWARDS LIFESCIENCES CORP | 3.1% |
|
CHARLES RIVER LABORATORIES | 3.0% |
 |
ARGENX SE ADR | 2.9% |
|
MODERNA, INC. | 2.6% |
|
AMGEN INC | 2.5% |
BMED Underweight Relative to HRTS
|
ELI LILLY & CO | -11.5% |
|
UNITEDHEALTH GROUP INC | -5.2% |
 |
NOVO NORDISK A/S-B | -5.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
|
ABBOTT LABORATORIES | -2.6% |
|
BRIDGEBIO PHARMA, INC. | -2.6% |
|
CYTOKINETICS INC | -2.5% |
|
ABBVIE INC | -2.4% |
 |
ASTRAZENECA PLC | -2.4% |
|
REVOLUTION MEDICINES, INC. | -2.3% |